Invention Grant
![[1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors](/docs/US/2015-01-27/US08940761B2/abs.jpg.600x600.jpg)
- Patent Title: [1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors
-
Application No.: US14361356Application Date: 2012-12-19
-
Publication No.: US08940761B2Publication Date: 2015-01-27
- Inventor: Simon Feldbæk Nielsen , Jens Christian Højland Larsen
- Applicant: Leo Pharma A/S
- Applicant Address: DK Ballerup
- Assignee: Leo Pharma A/S
- Current Assignee: Leo Pharma A/S
- Current Assignee Address: DK Ballerup
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- International Application: PCT/EP2012/076191 WO 20121219
- International Announcement: WO2013/092739 WO 20130627
- Main IPC: A61K31/437
- IPC: A61K31/437 ; C07D471/04
![[1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors](/abs-image/US/2015/01/27/US08940761B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to novel [1,2,4]triazolopyridine compounds with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
Public/Granted literature
- US20140329853A1 [1,2,4]TRIAZOLOPYRIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS Public/Granted day:2014-11-06
Information query
IPC分类:
